The Impact of the COVID Pandemic on the Incidence of Presentations with Cancer-Related Symptoms in Primary Care

Autor: Matthew P. Grant, Charles W. Helsper, Rebecca Stellato, Nicole van Erp, Kristel M. van Asselt, Pauline Slottje, Jean Muris, Daan Brandenbarg, Niek J. de Wit, Carla H. van Gils
Přispěvatelé: General practice, APH - Quality of Care, Family Medicine, RS: CAPHRI - R5 - Optimising Patient Care, APH - Personalized Medicine, CCA - Cancer Treatment and Quality of Life, APH - Health Behaviors & Chronic Diseases
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Cancers, 14(21):5353. MDPI AG
Grant, M P, Helsper, C W, Stellato, R, van Erp, N, van Asselt, K M, Slottje, P, Muris, J, Brandenbarg, D, de Wit, N J & van Gils, C H 2022, ' The Impact of the COVID Pandemic on the Incidence of Presentations with Cancer-Related Symptoms in Primary Care ', Cancers, vol. 14, no. 21, 5353 . https://doi.org/10.3390/cancers14215353
Cancers, 14(21):5353. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers; Volume 14; Issue 21; Pages: 5353
ISSN: 2072-6694
DOI: 10.3390/cancers14215353
Popis: Introduction: In the Netherlands, the onset of the coronavirus pandemic saw shifts in primary health service provision away from physical consultations, cancer-screening programs were temporarily halted, and government messaging focused on remaining at home. In March and April 2020, weekly cancer diagnoses decreased to 73% of their pre-COVID levels, and 39% for skin cancer. This study aims to explore the effect of the COVID pandemic on patient presentations for cancer-related symptoms in primary care in The Netherlands. Methods: Retrospective cohort study using routine clinical primary care data. Monthly incidences of patient presentations for cancer-related symptoms in five clinical databases in The Netherlands were analysed from March 2018 to February 2021. Results: Data demonstrated reductions in the incidence of cancer-related symptom presentations to primary care during the first COVID wave (March-June 2020) of −34% (95% CI: −43 to −23%) for all symptoms combined. In the second wave (October 2020–February 2021) there was no change in incidence observed (−8%, 95% CI −20% to 6%). Alarm-symptoms demonstrated decreases in incidence in the first wave with subsequent incidences that continued to rise in the second wave, such as: first wave: breast lump −17% (95% CI: −27 to −6%) and haematuria −15% (95% CI −24% to −6%); and second wave: rectal bleeding +14% (95% CI: 0 to 30%) and breast lump +14% (95% CI: 2 to 27%). Presentations of common non-alarm symptom such as tiredness and naevus demonstrated decreased in-cidences in the first wave of 45% (95% CI: −55% to −33%) and 37% (95% CI −47% to −25%). In the second wave, tiredness incidence was reduced by 20% (95% CI: −33% to −3%). Subgroup analy-sis did not demonstrate difference in incidence according to sex, age groups, comorbidity status, or previous history of cancer. Conclusions: These data describe large-scale primary care avoidance that did not increase until the end of the first COVID year for many cancer-related symptoms, suggestive that substantial numbers of patients delayed presenting to primary care. For those patients who had underlying cancer, this may have had impacted the cancer stage at diagnosis, treatment, and mortality.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje